Molecules
Molecules
Entries are grouped by medication category and recorded form. A combined program remains one entry with more than one identified ingredient. Molecules with no recorded program are kept on a watchlist rather than dropped, so the register says what it does not hold and why.
Held
- Brand exenatide1 entry
Byetta (exenatide) is indicated for adults with type 2 diabetes. An approved exenatide product does not establish weight-loss approval or which product, form or indication a provider offers. Indication source.
- Brand liraglutide12 entries
- Brand orforglipron9 entries
- Brand semaglutide114 entries
- Brand tirzepatide101 entries
- Compounded liraglutide1 entry
- Compounded semaglutide372 entries
- Compounded semaglutide + tirzepatide program2 entries
Combined program; contains semaglutide and tirzepatide. Exact coformulation is not established.
- Compounded tirzepatide374 entries
- Dulaglutide5 entries
Trulicity (dulaglutide) is indicated for type 2 diabetes and is not a weight-loss drug. An approved dulaglutide product does not establish weight-loss approval or which product, form or indication a provider offers. Indication source.
- Generic exenatide1 entry
Byetta (exenatide) is indicated for adults with type 2 diabetes. An approved exenatide product does not establish weight-loss approval or which product, form or indication a provider offers. Indication source.
- Generic liraglutide3 entries
- Liraglutide3 entries
- Oral semaglutide58 entries
- Semaglutide4 entries
- Tirzepatide6 entries
- Unspecified GLP-173 entries
Watchlist
Molecules we hold no programs for
The register has no recorded programs for these molecules. The historical classification snapshot dates to August 2026; an empty record does not itself establish whether a preparation can be supplied lawfully. Later additions carry their own dates; each molecule page explains what is recorded.
- TesamorelinApproved product, none recorded
- PT-141Approved product, none recorded
- SermorelinCompounding status requires review
- NAD+Compounding status requires review
- GlutathioneCompounding status requires review
- BPC-157No lawful route recorded
- MOTS-cNo lawful route recorded
- TB-500No lawful route recorded
- KPVNo lawful route recorded
- SemaxNo lawful route recorded
- EpitalonNo lawful route recorded
- GHK-CuNo lawful route recorded
- DSIPNo lawful route recorded
- Melanotan IINo lawful route recorded
- LL-37No lawful route recorded
- DihexaNo lawful route recorded
- PEG-MGFNo lawful route recorded
- Kisspeptin-10No lawful route recorded
- RetatrutideNo lawful route recorded
- CJC-1295No lawful route recorded
- IpamorelinNo lawful route recorded
- AOD-9604No lawful route recorded
- Thymosin alpha-1No lawful route recorded
- SelankNo lawful route recorded